Using ‘Omics’ to Develop Treatments for Drug-Resistant Cancer

Labiotech.eu, the leading digital media covering the European Biotech industry with over 150,000 monthly visitors, has selected AROMICS as one of the biotechs in Europe leading with OMIC technologies and its application to drug discovery and development.